Physician profile
Lisa Ann Devaney
NPI 1861984155
$26,819.68
in general payments reported to CMS, 2019-2025
23 companies · $462 in 2025
The $462 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,258 · 2022: $19K · 2023: $1,966 · 2024: $91.96 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,330 · Food and Beverage: $967 · Education: $199 · Travel and Lodging: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,330.00 |
| Food and Beverage | $966.95 |
| Education | $198.99 |
| Travel and Lodging | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $15,307.80 | 2021-2025 | Erleada, Akeega |
| Astellas Pharma US INC | $5,313.63 | 2021-2022 | |
| Pfizer INC. | $1,994.21 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $1,774.23 | 2021-2023 | Lynparza |
| Bayer Healthcare Pharmaceuticals INC. | $339.80 | 2021-2022 | |
| Myovant Sciences INC. | $312.17 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $274.52 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $243.74 | 2021-2025 | Lynparza |
| Gilead Sciences, INC. | $236.74 | 2023-2025 | Trodelvy |
| Janssen Scientific Affairs, LLC | $147.73 | 2021-2022 | |
| Axonics, INC. | $143.51 | 2022-2023 | Axonics |
| Teleflex LLC | $118.05 | 2021-2023 | Urolift |
| Boston Scientific Corporation | $111.89 | 2021-2024 | Rezum Generator |
| Exelixis INC. | $99.00 | 2023 | |
| Urovant Sciences INC | $92.62 | 2021-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $60.40 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $55.74 | 2022-2024 | |
| Tolmar Pharmaceuticals, INC. | $49.57 | 2021-2022 | |
| Amgen INC. | $46.35 | 2021 | |
| Progenics Pharmaceuticals, INC. | $33.08 | 2021-2022 | |
| Clovis Oncology, INC. | $24.30 | 2021 | |
| Blue Earth Diagnostics | $20.72 | 2021 | |
| Urogen Pharma, INC. | $19.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Devaney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.